Scarica l'app Stockscreener
13.17
8.66%
1.05
Dopo l'orario di chiusura:
13.12
-0.05
-0.38%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AUPH Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$12.12
Aprire:
$12.21
Volume 24 ore:
2.63M
Relative Volume:
1.36
Capitalizzazione di mercato:
$1.73B
Reddito:
$260.11M
Utile/perdita netta:
$60.64M
Rapporto P/E:
30.63
EPS:
0.43
Flusso di cassa netto:
$92.29M
1 W Prestazione:
+10.77%
1M Prestazione:
+19.19%
6M Prestazione:
+59.83%
1 anno Prestazione:
+82.66%
Intervallo 1D:
$12.07
$13.30
Intervallo di 1 settimana:
$11.88
$13.30
Portata 52W:
$6.55
$13.54
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
Nome
Aurinia Pharmaceuticals Inc
Settore
Industria
Telefono
250-744-2487
Indirizzo
#140, 14315 - 118 AVENUE, EDMONTON, BC
Confronta AUPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
13.17 | 1.60B | 260.11M | 60.64M | 92.29M | 0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-30 | Ripresa | H.C. Wainwright | Buy |
| 2022-11-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-05-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-12-10 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-10-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-01-25 | Reiterato | H.C. Wainwright | Buy |
| 2020-11-03 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-05-05 | Iniziato | Cowen | Outperform |
| 2020-01-10 | Iniziato | Jefferies | Buy |
| 2019-12-16 | Reiterato | H.C. Wainwright | Buy |
| 2018-03-16 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-02-08 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-10-30 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-18 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-03-22 | Reiterato | FBR & Co. | Outperform |
| 2016-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-17 | Reiterato | H.C. Wainwright | Buy |
| 2016-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2015-05-08 | Iniziato | MLV & Co | Buy |
Mostra tutto
Aurinia Pharmaceuticals Inc Borsa (AUPH) Ultime notizie
Will Aurinia Pharmaceuticals Inc. stock recover faster than marketProduct Launch & Comprehensive Market Scan Reports - newser.com
Top FDA official Tidmarsh resigns after comments on kidney drug, HHS probe - Seeking Alpha
FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ - Stocktwits
FDA Official Steps Down, Sued by Drugmaker - The Wall Street Journal
Key metrics from Aurinia Pharmaceuticals Inc.’s quarterly dataTrade Exit Summary & Reliable Intraday Trade Alerts - newser.com
What analysts say about Aurinia Pharmaceuticals Inc IKAP stockMACD Trading Signals & Double Digit Wealth Tips - earlytimes.in
Visualizing Aurinia Pharmaceuticals Inc. stock with heatmaps2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com
Chart overlay techniques for tracking Aurinia Pharmaceuticals Inc.Market Performance Summary & Community Consensus Picks - newser.com
Why Aurinia Pharmaceuticals Inc. is moving todayEarnings Overview Report & Real-Time Buy Zone Alerts - newser.com
Using R and stats models for Aurinia Pharmaceuticals Inc. forecastingProfit Target & Weekly Market Pulse Alerts - newser.com
Can Aurinia Pharmaceuticals Inc. stock reach $100 price targetJuly 2025 Intraday Action & Free Weekly Watchlist of Top Performers - newser.com
Is There An Opportunity With Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) 49% Undervaluation? - Yahoo Finance
Analyzing drawdowns of Aurinia Pharmaceuticals Inc. with statistical toolsQuarterly Portfolio Summary & Target Return Focused Picks - newser.com
Is Aurinia Pharmaceuticals Inc. (IKAP) stock undervalued historicallyMarket Performance Report & Weekly Breakout Opportunity Watchlist - newser.com
Aurinia Pharmaceuticals (AUPH) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Using data models to predict Aurinia Pharmaceuticals Inc. stock movementJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
Is Aurinia Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 Final Week & Expert Approved Trade Ideas - newser.com
Combining price and volume data for Aurinia Pharmaceuticals Inc.Weekly Profit Report & Detailed Earnings Play Strategies - newser.com
Is Aurinia Pharmaceuticals Inc. building a consolidation baseMarket Volume Report & High Accuracy Trade Signal Alerts - newser.com
Will breakout in Aurinia Pharmaceuticals Inc. lead to full recoveryTrade Volume Report & High Conviction Trade Alerts - newser.com
Is Aurinia Pharmaceuticals Inc. (IKAP) stock a good hedge against inflation2025 Biggest Moves & AI Powered Buy and Sell Recommendations - newser.com
Is Aurinia Pharmaceuticals Inc. stock vulnerable to regulatory risksAnalyst Downgrade & High Accuracy Swing Trade Signals - Fundação Cultural do Pará
Aurinia Pharmaceuticals Inc Azioni (AUPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):